AVEO Stock: Up on Collaboration With BMY
AVEO Oncology (NASDAQ: AVEO) recently announced the FDA approval of FOTIVDA. So, the stock has been on the radar of several investors are commercialization will commence in the next couple of months. Now, the company is looking to take the treatment another step forward, with an announcement this morning that it has entered into a … Read more